Article
Sticking to therapy: bioequivalence assessment and adhesion performance of rivastigmine transdermal patch formulations
2026-08-11
Abstract excerpt
<title>Abstract</title> <p> Background: Rivastigmine transdermal drug delivery systems (TDDS) provide smoother plasma concentration profiles and improved tolerability compared with oral formulations. <h4>Methods:</h4> This study aimed to evaluate the bioequivalence, adhesion performance, and safety profile of a branded generic rivastigmine TDDS, Rivazich (13.68 mg, 9.5 mg/24 h) compared with the reference produc...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d6511b0d-8c87-513e-9224-e307d0307bb1
- DOI
- 10.21203/rs.3.rs-9692373/v1
